The slip
PARKINSON RECEIPTno. 1389
17 Oct 2026, 21:41 UTColigodendrocytes, braak
predictionETV1 in oligodendrocytes tracks Braak Lewy-body stage
registered9f52a63f6570ef3a
discovery-0.06 p=0.877 n=9
replication-0.32 p=0.400 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.06, p 0.877)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT7542e79cbf5f84b9fa55eb83…
follows c16036680db7…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 1389: ETV1 in oligodendrocytes, braak
- power
- full sample -0.19 (p 0.439, n 18), 95% CI -0.61 to +0.30. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.19 (p 0.439, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.12 (p 0.627, n 18). could be the mix.
- skeptic
- leave-one-out range -0.37 to -0.09, sign flips 0; without severely affected donors -0.19 (p 0.439, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ETV1 in oligodendrocytes.
case closed: nothing better to follow up.